Guerlain retires
This article was originally published in The Rose Sheet
Executive Summary
Master perfumer Jean-Paul Guerlain has retired as head of the Parisian fragrance house after 47 years, LVMH announces. Guerlain will focus on writing his memoirs, which are expected to be published in October. Fifth-generation perfumer assumed the helm of the 174-year-old company in 1959. During his tenure, Guerlain was instrumental in bringing to market more than 60 fragrances including Vetiver (1959), Nahema (1979), Samsara (1989), Héritage (1992) and his most personal offering, Mahora (2001). Creation of Mahora was designed as a testament to beautiful, sexy women of all ages (11"The Rose Sheet" Nov. 20, 2000, p. 5). Guerlain's retirement follows the resignation of U.S. President and CEO Marjorie Wollan (22"The Rose Sheet" Nov. 5, 2001, p. 8)...
You may also be interested in...
Guerlain Mahora Fragrance Blossoms Under $2 Mil.-$3 Mil. Ad Campaign
Perfumer Jean-Paul Guerlain's latest and most modern fragrance, Mahora, will bow stateside in April backed by a $2 mil.-$3 mil. ad spend, the LVMH company said at a press event in New York City Nov. 15.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip